|
2016-12-05 |
2016-12-02 |
B
Purchase
|
MADDALUNA ANTHONY J
Non-Executive Director
|
1,518
+25.8%
16.46
USD 24,986
|
1,518
+25.8%
|
16.46
|
USD 24,986
|
|
|
2016-12-01 |
2016-11-30 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
9,000
-20.5%
16.71
USD 150,390
|
9,000
-20.5%
|
16.71
|
USD 150,390
|
|
|
2016-11-17 |
2016-11-16 |
S
Sale
|
HENDERSON LORI M.
SVP, Secretary & Gen Counsel
Officer
|
6,000
-10.5%
17.00
USD 102,000
|
6,000
-10.5%
|
17.00
|
USD 102,000
|
|
|
2016-11-10 |
2016-11-10 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
785
-2.2%
16.79
USD 13,180
|
785
-2.2%
|
16.79
|
USD 13,180
|
|
|
2016-08-10 |
2016-08-09 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
1,401
-3.7%
15.29
USD 21,421
|
1,401
-3.7%
|
15.29
|
USD 21,421
|
|
|
2016-06-01 |
2016-05-31 |
S
Sale
|
OCONNOR KEVIN
Non-Executive Director
|
5,000
-9.4%
14.41
USD 72,050
|
5,000
-9.4%
|
14.41
|
USD 72,050
|
|
|
2016-05-16 |
2016-05-16 |
B
Purchase
|
Marth William S
President and CEO
Executive Director
|
12,500
+2.4%
12.86
USD 160,750
|
12,500
+2.4%
|
12.86
|
USD 160,750
|
|
|
2016-05-16 |
2016-05-13 |
B
Purchase
|
Svokos George
Chief Operating Officer
Officer
|
12,500
+13.0%
12.82
USD 160,250
|
12,500
+13.0%
|
12.82
|
USD 160,250
|
|
|
2016-05-16 |
2016-05-13 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
2,361
-5.9%
12.77
USD 30,150
|
2,361
-5.9%
|
12.77
|
USD 30,150
|
|
|
2015-11-10 |
2015-11-09 |
S
Sale
|
D AMBRA CONSTANCE M
Large shareholder
|
50,000
-2.1%
19.60
USD 980,000
|
50,000
-2.1%
|
19.60
|
USD 980,000
|
|
|
2015-11-10 |
2015-11-09 |
S
Sale
|
D AMBRA THOMAS E
Chairman, Board of Directors
Non-Executive Director
|
50,000
-2.0%
19.60
USD 980,000
|
50,000
-2.0%
|
19.60
|
USD 980,000
|
|
|
2015-08-17 |
2015-08-17 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
1,000
-3.4%
20.45
USD 20,450
|
1,000
-3.4%
|
20.45
|
USD 20,450
|
|
|
2015-08-10 |
2015-08-07 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
5,000
-14.8%
21.06
USD 105,300
|
5,000
-14.8%
|
21.06
|
USD 105,300
|
|
|
2015-06-09 |
2015-06-08 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
5,000
-14.8%
19.99
USD 99,950
|
5,000
-14.8%
|
19.99
|
USD 99,950
|
|
|
2015-06-08 |
2015-06-04 |
B
Purchase
|
Marth William S
President and CEO
Executive Director
|
10,000
+2.3%
19.98
USD 199,800
|
10,000
+2.3%
|
19.98
|
USD 199,800
|
|
|
2015-06-05 |
2015-06-04 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
787
-2.7%
19.58
USD 15,409
|
787
-2.7%
|
19.58
|
USD 15,409
|
|
|
2015-06-04 |
2015-06-02 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
3,750
-11.3%
19.39
USD 72,713
|
3,750
-11.3%
|
19.39
|
USD 72,713
|
|
|
2015-05-11 |
2015-05-08 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
7,500
-19.4%
19.20
USD 144,000
|
7,500
-19.4%
|
19.20
|
USD 144,000
|
|
|
2015-05-11 |
2015-05-08 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
7,000
-18.3%
19.35
USD 135,450
|
7,000
-18.3%
|
19.35
|
USD 135,450
|
|
|
2015-03-19 |
2015-03-17 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
3,500
-11.2%
18.53
USD 64,855
|
3,500
-11.2%
|
18.53
|
USD 64,855
|
|
|
2015-03-16 |
2015-03-13 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
441
-1.4%
18.79
USD 8,286
|
441
-1.4%
|
18.79
|
USD 8,286
|
|
|
2015-03-13 |
2015-03-12 |
S
Sale
|
OCONNOR KEVIN
Non-Executive Director
|
5,000
-10.4%
18.22
USD 91,100
|
5,000
-10.4%
|
18.22
|
USD 91,100
|
|
|
2015-03-13 |
2015-03-12 |
S
Sale
|
ROTH ARTHUR J
Non-Executive Director
|
5,000
-11.2%
18.26
USD 91,300
|
5,000
-11.2%
|
18.26
|
USD 91,300
|
|
|
2015-03-12 |
2015-03-11 |
S
Sale
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Officer
|
721
-2.2%
18.30
USD 13,194
|
721
-2.2%
|
18.30
|
USD 13,194
|
|
|
2015-03-11 |
2015-03-10 |
B
Purchase
|
Svokos George
Chief Commercial Officer
Officer
|
10,000
+16.5%
17.72
USD 177,200
|
10,000
+16.5%
|
17.72
|
USD 177,200
|
|
|
2015-03-06 |
2015-03-05 |
B
Purchase
|
Marth William S
President and CEO
Executive Director
|
20,000
+5.1%
17.70
USD 354,000
|
20,000
+5.1%
|
17.70
|
USD 354,000
|
|
|
2015-02-27 |
2015-02-25 |
S
Sale
|
Nolan Michael M
CFO
Officer
|
5,000
-6.8%
16.17
USD 80,850
|
5,000
-6.8%
|
16.17
|
USD 80,850
|
|
|
2015-02-25 |
2015-02-23 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
3,750
-13.0%
16.22
USD 60,825
|
3,750
-13.0%
|
16.22
|
USD 60,825
|
|
|
2015-02-20 |
2015-02-18 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
1,250
-4.7%
16.46
USD 20,575
|
1,250
-4.7%
|
16.46
|
USD 20,575
|
|
|
2015-02-20 |
2015-02-18 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
3,750
-13.0%
16.60
USD 62,250
|
3,750
-13.0%
|
16.60
|
USD 62,250
|
|
|
2015-02-20 |
2015-02-18 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
1,623
-6.1%
16.48
USD 26,747
|
1,623
-6.1%
|
16.48
|
USD 26,747
|
|
|
2014-12-05 |
2014-12-04 |
PS
Planned sale
|
CABLE STUART M
Large shareholder
|
10,391
-0.3%
16.00
USD 166,262
|
10,391
-0.3%
|
16.00
|
USD 166,262
|
|
|
2014-11-18 |
2014-11-14 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
10,500
-25.3%
16.06
USD 168,630
|
10,500
-25.3%
|
16.06
|
USD 168,630
|
|
|
2014-11-12 |
2014-11-10 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
7,500
-19.5%
17.03
USD 127,725
|
7,500
-19.5%
|
17.03
|
USD 127,725
|
|
|
2014-11-10 |
2014-11-10 |
B
Purchase
|
Marth William S
President and CEO
Executive Director
|
30,000
+9.6%
17.01
USD 510,300
|
30,000
+9.6%
|
17.01
|
USD 510,300
|
|
|
2014-09-02 |
2014-08-28 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
1,250
-3.9%
19.74
USD 24,675
|
1,250
-3.9%
|
19.74
|
USD 24,675
|
|
|
2014-08-14 |
2014-08-14 |
S
Sale
|
Nolan Michael M
SVP, CFO and Treasurer
Officer
|
10,000
-11.6%
19.76
USD 197,600
|
10,000
-11.6%
|
19.76
|
USD 197,600
|
|
|
2014-08-13 |
2014-08-12 |
S
Sale
|
HENDERSON LORI M
SVP, Secretary & Gen. Counsel
Officer
|
30,000
-40.2%
19.05
USD 571,500
|
30,000
-40.2%
|
19.05
|
USD 571,500
|
|
|
2014-08-12 |
2014-08-08 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
10,000
-24.4%
18.99
USD 189,900
|
10,000
-24.4%
|
18.99
|
USD 189,900
|
|
|
2014-08-12 |
2014-08-08 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
797
-2.5%
18.99
USD 15,135
|
797
-2.5%
|
18.99
|
USD 15,135
|
|
|
2014-06-04 |
2014-06-03 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
2,500
-7.3%
16.93
USD 42,325
|
2,500
-7.3%
|
16.93
|
USD 42,325
|
|
|
2014-05-20 |
2014-05-16 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
1,250
-3.6%
15.45
USD 19,313
|
1,250
-3.6%
|
15.45
|
USD 19,313
|
|
|
2014-05-16 |
2014-05-15 |
B
Purchase
|
Svokos George
SVP Sales & GM of API
Officer
|
10,000
+22.4%
15.60
USD 156,000
|
10,000
+22.4%
|
15.60
|
USD 156,000
|
|
|
2014-05-13 |
2014-05-12 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
2,500
-7.0%
15.27
USD 38,175
|
2,500
-7.0%
|
15.27
|
USD 38,175
|
|
|
2014-05-13 |
2014-05-12 |
B
Purchase
|
Marth William S
President and CEO
Executive Director
|
30,000
+10.6%
15.40
USD 462,000
|
30,000
+10.6%
|
15.40
|
USD 462,000
|
|
|
2014-05-13 |
2014-05-09 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
2,500
-7.0%
14.80
USD 37,000
|
2,500
-7.0%
|
14.80
|
USD 37,000
|
|
|
2014-05-13 |
2014-05-09 |
S
Sale
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Officer
|
897
-2.6%
14.80
USD 13,276
|
897
-2.6%
|
14.80
|
USD 13,276
|
|
|
2014-02-28 |
2014-02-27 |
S
Sale
|
ROTH ARTHUR J
Non-Executive Director
|
5,000
-11.9%
15.95
USD 79,750
|
5,000
-11.9%
|
15.95
|
USD 79,750
|
|
|
2014-02-27 |
2014-02-27 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
3,000
-7.9%
15.73
USD 47,190
|
3,000
-7.9%
|
15.73
|
USD 47,190
|
|
|
2014-02-25 |
2014-02-25 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
2,500
-6.7%
15.19
USD 37,975
|
2,500
-6.7%
|
15.19
|
USD 37,975
|
|
|
2014-02-25 |
2014-02-24 |
S
Sale
|
Nolan Michael M
VP, CFO and Treasurer
Officer
|
15,000
-16.5%
15.00
USD 225,000
|
15,000
-16.5%
|
15.00
|
USD 225,000
|
|
|
2014-02-24 |
2014-02-21 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
1,500
-4.1%
14.87
USD 22,305
|
1,500
-4.1%
|
14.87
|
USD 22,305
|
|
|
2014-02-19 |
2014-02-19 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
1,500
-4.0%
13.37
USD 20,055
|
1,500
-4.0%
|
13.37
|
USD 20,055
|
|
|
2013-12-04 |
2013-12-04 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
2,500
-8.4%
10.93
USD 27,325
|
2,500
-8.4%
|
10.93
|
USD 27,325
|
|
|
2013-12-04 |
2013-12-03 |
B
Purchase
|
Marth William S
Non-Executive Director
|
30,000
+49.1%
10.75
USD 322,500
|
30,000
+49.1%
|
10.75
|
USD 322,500
|
|
|
2013-11-22 |
2013-11-22 |
B
Purchase
|
Marth William S
Non-Executive Director
|
20,000
+48.6%
11.57
USD 231,400
|
20,000
+48.6%
|
11.57
|
USD 231,400
|
|
|
2013-11-22 |
2013-11-22 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
2,300
-7.7%
11.55
USD 26,565
|
2,300
-7.7%
|
11.55
|
USD 26,565
|
|
|
2013-06-04 |
2013-06-03 |
B
Purchase
|
Marth William S
Non-Executive Director
|
10,000
+35.3%
10.23
USD 102,300
|
10,000
+35.3%
|
10.23
|
USD 102,300
|
|
|
2013-05-31 |
2013-05-29 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
800
-2.5%
11.26
USD 9,008
|
800
-2.5%
|
11.26
|
USD 9,008
|
|
|
2013-05-23 |
2013-05-22 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
7,500
-11.6%
10.97
USD 82,275
|
7,500
-11.6%
|
10.97
|
USD 82,275
|
|
|
2013-05-13 |
2013-05-10 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
1,200
-3.6%
10.40
USD 12,480
|
1,200
-3.6%
|
10.40
|
USD 12,480
|
|
|
2013-03-20 |
2013-03-19 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
258
-0.4%
9.91
USD 2,557
|
258
-0.4%
|
9.91
|
USD 2,557
|
|
|
2013-03-20 |
2013-03-19 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
180
-0.5%
9.91
USD 1,784
|
180
-0.5%
|
9.91
|
USD 1,784
|
|
|
2013-03-20 |
2013-03-18 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
256
-0.4%
9.98
USD 2,555
|
256
-0.4%
|
9.98
|
USD 2,555
|
|
|
2013-03-20 |
2013-03-18 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
249
-0.7%
9.98
USD 2,485
|
249
-0.7%
|
9.98
|
USD 2,485
|
|
|
2013-03-13 |
2013-03-13 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
852
-1.5%
10.69
USD 9,108
|
852
-1.5%
|
10.69
|
USD 9,108
|
|
|
2013-03-14 |
2013-03-12 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
677
-1.9%
10.75
USD 7,278
|
677
-1.9%
|
10.75
|
USD 7,278
|
|
|
2013-03-13 |
2013-03-12 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
694
-1.2%
10.75
USD 7,461
|
694
-1.2%
|
10.75
|
USD 7,461
|
|
|
2013-03-13 |
2013-03-12 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
1,070
-1.8%
10.73
USD 11,481
|
1,070
-1.8%
|
10.73
|
USD 11,481
|
|
|
2013-03-13 |
2013-03-11 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
3,538
-5.5%
10.25
USD 36,265
|
3,538
-5.5%
|
10.25
|
USD 36,265
|
|
|
2013-03-11 |
2013-03-07 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
1,000
-2.8%
9.56
USD 9,560
|
1,000
-2.8%
|
9.56
|
USD 9,560
|
|
|
2013-02-26 |
2013-02-22 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
984
-2.7%
8.18
USD 8,049
|
984
-2.7%
|
8.18
|
USD 8,049
|
|
|
2013-02-26 |
2013-02-22 |
S
Sale
|
Sargent Bruce J
Sr VP, Drug Discovery
Officer
|
984
-1.5%
8.18
USD 8,049
|
984
-1.5%
|
8.18
|
USD 8,049
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Officer
|
1,000
-2.6%
7.89
USD 7,890
|
1,000
-2.6%
|
7.89
|
USD 7,890
|
|
|
2012-12-04 |
2012-12-03 |
B
Purchase
|
Marth William S
Non-Executive Director
|
10,000
+80.3%
5.00
USD 50,000
|
10,000
+80.3%
|
5.00
|
USD 50,000
|
|
